Login to Your Account

Spin-outs Spinning Faster

Theravance Divides its Assets into Two Separate Businesses

By Peter Winter
BioWorld Insight Editor

Tuesday, April 30, 2013
Spinning out assets into a new corporate entity is a business strategy that is starting to gain traction once again. Theravance Inc., of South San Francisco, is the latest company to join several pharmaceutical and biotechnology firms, including Abbott, Pfizer Inc. and Resverlogix Corp. to reveal that undertaking.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription